Levofloxacine Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacine Fresenius Kabi, is a fluoroquinolone antibiotic presented as an intravenous solution for IV use. It treats a range of bacterial infections, including respiratory, urinary, and skin infections, and is commonly employed in hospital settings.

GNH USA supplies Levofloxacine Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare institutions. Clients benefit from consistent product availability and regulatory support across multiple regions.

Levofloxacin is a broad‑spectrum fluoroquinolone antibiotic used to treat bacterial infections in various organ systems.

- Community‑acquired pneumonia: achieves bacterial eradication in the lungs, improving respiratory symptoms and preventing complications. - Urinary tract infections: clears uropathogenic bacteria, relieving dysuria and reducing risk of renal involvement. - Skin and soft tissue infections: eliminates causative organisms, promoting wound healing and reducing inflammation. - Acute sinusitis: resolves sinus mucosal infection, alleviating congestion and facial pain. - Acute exacerbations of chronic bronchitis: reduces bacterial load, improving airflow and decreasing exacerbation severity.

Levofloxacin may cause a range of adverse reactions, from mild to severe, that clinicians monitor during therapy.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient cranial discomfort. - Rash: skin erythema or mild itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT interval prolongation: cardiac rhythm disturbance that may lead to arrhythmia. - Clostridioides difficile infection: severe colitis following disruption of gut flora.

When prescribing levofloxacin, several precautionary measures should be observed to minimize risks. - Assess renal function: adjust dosing in patients with impaired clearance. - Monitor for tendon pain: discontinue therapy if signs of tendonitis or rupture appear. - Avoid concomitant QT‑prolonging drugs: reduce risk of cardiac arrhythmias. - Use cautiously in patients with a history of seizures: may lower seizure threshold. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with other medicines, altering efficacy or safety; awareness of key interactions is essential.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Theophylline: increased plasma concentrations leading to toxicity. - Cyclosporine: heightened risk of nephrotoxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Corticosteroids: additive risk of tendon rupture. - Diabetes medications: possible alteration of glucose control.